Hillstar Bio | $67,000,000 | (Apr 2, 2025)
Sympera AI | $10,000,000 | (Apr 2, 2025)
LTV.ai | $5,200,000 | (Apr 2, 2025)
Certified by Founder
Lodge
Tenvie Therapeutics
start up
United States
- South San Francisco, California
- 09/01/2025
- Unknown
- $200,000,000
Tenvie is a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases. The company’s foundation is purpose-built with a diverse portfolio of small molecules and a proven team of CNS drug developers to rapidly deliver multiple clinical assets. Tenvie is advancing a pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases. Its portfolio of wholly owned, highly brain-penetrant, and precision-designed peripherally restricted small molecules address three key drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function.
- Industry Biotechnology Research
- Website https://tenvie.com/
- LinkedIn https://www.linkedin.com/company/tenvie-therapeutics/
Sturdy | $6,000,000 | (Apr 2, 2025)
Tomorro | $26,995,875 | (Apr 2, 2025)
voize | $9,000,000 | (Apr 2, 2025)
EVident Battery, Inc. | $3,200,000 | (Apr 2, 2025)
Notable Systems | $12,000,000 | (Apr 2, 2025)
LightSource | $33,000,000 | (Apr 2, 2025)
Atomic(US) | $10,000,000 | (Apr 2, 2025)
ControlTheory | $5,000,000 | (Apr 2, 2025)
Marit Health | $3,200,000 | (Apr 1, 2025)